Form 10-Q · Quarterly report
Medtronic 10-Q, filed Sep 3, 2026
- Filed
- CIK
- 0001613103
- Accession no.
- 0001628280-26-060473
Summary
Medtronic reported GAAP diluted earnings per share of $1.14 and non-GAAP diluted EPS of $1.45 for the fiscal quarter ended July 31, 2026, up from $0.81 and $1.26 a year earlier, with free cash flow of $1.29 billion versus $584 million. The company also reorganized its Cardiovascular Portfolio divisions into four units starting in fiscal 2027, continued planning the separation of its Diabetes Business, and noted the U.S. Supreme Court's February 20, 2026 ruling that President Trump's IEEPA tariff policies are unconstitutional, after which it participated in Customs and Border Protection refund processes.
Key points
- Medtronic's first quarter of fiscal 2027 spanned 53 weeks, with the extra week falling in the first fiscal month and included in results for the three months ended July 31, 2026.
- Net cash provided by operating activities was $1.793 billion for the quarter ended July 31, 2026, compared with $1.088 billion a year earlier.
- The Cardiovascular Portfolio divisions were reorganized into Electrophysiology Therapies, Interventional Cardiology Therapies, CardioVascular Surgery, and Peripheral Vascular Health, and prior-period net sales were recast.
- Medtronic stated that further escalation or expansion of trade barriers could have a material adverse effect on its results of operations.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations UNDERSTANDING OUR FINANCIAL INFORMATION The following discussion and analysis provides information management believes to be relevant to understanding the financial condition and results of operations of Medtronic plc and its subsidiaries (Medtronic plc, Medtronic, or the Company, or we, us, or our). For a full understanding of financial condition and results of operations, this discussion and analysis should be read along with Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended April 24, 2026, as filed…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.